|
[1]RAO ZG,GAO JF,ZHANG BC,et al.Clinical observation of breast cancer liver metastasis after mastectomy by combined treatment of transarterial chemoembolization(TACE)and systemic chemotherapy[J].J Mod Oncol,2013,21(9):1994-1996.(in Chinese)饶智国,高建飞,章必成,等.全身化疗联合肝动脉栓塞化疗治疗乳腺癌术后肝转移的临床疗效观察[J].现代肿瘤医学,2013,21(9):1994-1996.
|
|
[2]WALKER MS,HASAN M,YIM YM,et al.Retrospective study of the effect of disease progression on patient reported outcomes in HER-2negative metastatic breast cancer patients[J].Health Qual Life Outcomes,2011,9:46.
|
|
[3]ZHANG P,XU EJ,HUANG Y,et al.Curative effect of radiofrequency ablation combined with chemotherapy for liver metastases from breast cancer in 6 cases[J/CD].Chin J Hepatic Surg:Electronic Edition,2014,3(5):299-302.(in Chinese)张鹏,许尔蛟,黄勇,等.射频消融联合化疗治疗乳腺癌肝转移六例疗效分析[J/CD].中华肝脏外科手术学电子杂志,2014,3(5):299-302.
|
|
[4]AARONSON NK,AHMEDZAI S,BERGMAN B,et al.The European Organization for research and treatment of cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology[J].J Natl Cancer Inst,1993,85(5):365-376.
|
|
[5]LIU CF,YAN JJ,LI J,et al.Partial hepatectomy for liver metastases from breast cancer:a retrospective study of 47 patients[J].Chin J Hepatobiliary Surg,2012,18(6):420-423.(in Chinese)刘才峰,晏建军,李静,等.乳腺癌术后肝脏转移的手术治疗:47例回顾性分析[J].中华肝胆外科杂志,2012,18(6):420-423.
|
|
[6]DONG Y,KANG LH,GUAN M,et al.Clinical effect and influencing factor analysis of postoperative adjurant therapy for patients with breast cancer[J].J Jilin Univ:Med Edit,2015,41(3):636-642.(in Chinese)董营,康丽花,关萌,等.乳腺癌患者术后辅助治疗的临床效果及其影响因素分析[J].吉林大学学报:医学版,2015,41(3):636-642.
|
|
[7]LALISANG RI,ERDKAMP FL,RODENBURG CJ.Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer:a randomized phaseⅡstudy of dose-dense and dose-escalated chemotherapy[J].Breast Cancer Res Treat,2011,128(2):437-445.
|
|
[8]MIN WL,WANG XJ,LIU XX,et al.Diagnosis and treatment of39 cases of breast cancer patients with liver metastases[J].J Mod Oncol,2014,22(7):1592-1594.(in Chinese)闵卫利,王西京,刘小旭,等.39例乳腺癌并肝转移诊治体会[J].现代肿瘤医学,2014,22(7):1592-1594.
|
|
[9]WU QC.Effect comparison of different chemotherapy regimens of capecitabine in breast cancer liver metastasis[J].China Modern Med,2015,22(11):63-65.(in Chinese)吴庆成.卡培他滨不同化疗方案治疗乳腺癌肝转移的效果对比[J].中国当代医药,2015,22(11):63-65.
|
|
[10]XIE J,CHEN RP,ZHANG YF,et al.The clinical effects of navelbine plus platinum chemotherapy on recurrent metastatic breast cancer of elderly patients[J].Anti-Tumor Pharm,2015,5(3):209-212.(in Chinese)夏金,陈瑞萍,张彦芳,等.诺维本联合铂类二线化疗治疗老年复发转移性乳腺癌的疗效分析[J].肿瘤药学,2015,5(3):209-212.
|
|
[11]ZHAO ZB.Surgical treatment for patients with liver metastasis after breast cancer surgery[J].Zhejiang Clin Med J,2012,14(3):268-270.(in Chinese)赵宗彬.乳腺癌术后肝转移患者的手术治疗分析[J].浙江临床医学,2012,14(3):268-270.
|
|
[12]TSIMBERIDOU AM,LETOURNEAU K,FU S,et al.PhaseⅠclinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement[J].Cancer Chemother Pharmacol,2011,68(1):247-253.
|
|
[13]ZHAO ZB,JIAN ZY.The Retrospective analysis of the treatment for alone hepatic metastatic breast carcinoma not suitable for excision after the primary lesion removal[J].J Hubei Univ Med,2012,31(3):204-208.(in Chinese)赵宗彬,菅志远.无法手术切除的乳腺癌单纯性肝转移患者治疗的回顾性分析[J].湖北医药学院学报,2012,31(3):204-208.
|
|
[14]CHEN YL,WANG YF,LIU K,et al.Clinical research on TX and NX regimens in treatment of liver metastasis of breast cancer[J].Matern Child Health Care China,2014,29(34):5695-5697.(in Chinese)陈云兰,王羽丰,刘坤,等.TX与NX方案治疗乳腺癌肝转移的临床研究[J].中国妇幼保健,2014,29(34):5695-5697.
|
|
[15]HUA YY.Efficacy analysis of intervention for metastatic breast cancer[J].Anti-Tumor Pharm,2011,1(5):462-463,466.(in Chinese)华燕艳.乳腺癌肝转移介入治疗疗效分析[J].肿瘤药学,2011,1(5):462-463,466.
|
|
[16]GADALETA CD,RANIERI G.Trans-arterial chemoembolization as a therapy for liver tumours:new clinical developments and suggestions for combination with angiogenesis inhibitors[J].Crit Rev Oncol Hematol,2011,80(1):40-53.
|
DownLoad: